Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 822 results for "federal patent court"

Myriad Genetics (MYGN) Loses Gene Testing Patent Appeal To Ambry
Bidness Etc

Myriad's Breast Cancer Test Patents Not Patent Eligible

Following a 2013 decision in which the Supreme Court invalidated Myriad Genetics, Inc.'s patents on human genes , the Federal Circuit this month went a step further, and held that Myriad's breast cancer test patents are also patent ineligible under ... National Law Review, 9 hours ago
Myriad loses a battle in BRCA patent war Fierce BioMarkers, 1 day ago

17 images for federal patent court

Financial Express, 2 weeks ago
The Global Legal Post, 1 month ago
Money Today, 2 weeks ago
One News Page United Kingdom, 1 month ago, 1 month ago
Intellectual Asset Management, 4 weeks ago
Jagran Post, 1 month ago
DailyTech, 1 month ago
JD Supra, 1 month ago
Today's General Counsel, 1 month ago

Ambry prevails in patent case against Myriad

News Editor The U.S. Court of Appeals for the Federal Circuit finds that three of the patents covering DNA-based BRC1 and BRCA2 tests asserted by Myriad Genetics (NASDAQ:MYGN) against privately-held reference laboratory Ambry Genetics do not ...
 Seeking Alpha3 days ago

Cisco Systems Sues Rival for Infringement of Network Patents

The lawsuits, filed in a federal court in California, accuse Arista of infringing on 14 patents on networks and also on related copyrights, Cisco General Counsel Mark Chandler said in a blog post. Shares of Arista were down 6.9 percent at $68.48 in afternoon ...
 NDTV2 weeks ago Cisco Sues Jayshree Ullal's Arista for Patent Violations  India-West1 week ago

Merck committed to Cubist after patent losses

Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the company's patents protecting its top-selling antibiotic just hours after the deal was announced this week. Merck ...
 CNBC1 week ago Merck pledges commitment to $8.4 billion Cubist deal after court ruling on Cubicin patents  INO.com1 week ago CUBIST PHARMACEUTICALS : Merck committed to Cubist after patent losses  4 Traders1 week ago
Money Today

Cipla sues Canada-based Apotex to enforce allergy drug patents

Cipla said in a filing to the BSE that "they sued Apotex Inc and Apotex Corp in Federal District Court in Delaware to enforce the Orange-Book listed patents covering 'Dymista' Nasal Spray". It further said that it has sued Apotex Inc and Apotex C
 Money Today2 weeks ago Meda Pharma, Cipla sue Apotex over Dymista patents  Business Line2 weeks ago Meda and Cipla sue Apotex to enforce Dymista patents  Money Control2 weeks ago

Federal Circuit Rules on Patent Licensing Fees

The top U.S. patent court, for the first time, is stepping into a debate that has splintered the technology community over how to value patents that cover essential technologies like Wi-Fi. Ruling on Ericsson AB's contribution to the industry ...
 GigaLaw.com1 week ago Court Steps Into Patent Debate That Split Technology Companies  BusinessWeek2 weeks ago
Jagran Post

Samsung fires back at Nvidia with chip patents lawsuit

Samsung, which filed its lawsuit in a US federal court on Nov. 4, is seeking damages for deliberate infringement of several technical patents, including a few that govern the way semiconductors buffer and use data. SAN FRANCISCO: Samsung Electronics Co Ltd ...
 Economic Times1 month ago Samsung Electronics fires back at Nvidia with chip patents lawsuit  Jagran Post1 month ago Samsung brings arbitration against Microsoft after royalty lawsuit  Jagran Post2 months ago

Nintendo Wins Appeal: Creative Kingdoms Patents Invalid

Today the federal appeals court confirmed Nintendo's win in a patent infringement case brought at the International Trade Commission by Creative Kingdoms. The court affirmed earlier findings by the ITC that Creative Kingdoms ...
 Crawford Financial Planning1 day ago Nintendo wins patent troll's appeal and can keep selling the Wii U  Venturebeat1 day ago NINTENDO WINS APPEAL : Creative Kingdoms Patents Invalid  4 Traders1 day ago

Federal Circuit Invalidates Myriad Primer and Method Claims as Lacking Subject Matter Eligibility

In a case styled as In re BRCA1- and BRCA2-Based Hereditary Cancer Test Patent Litigation (also known as Myriad v. Ambry ), the Federal Circuit held four of Myriad's primer claims and two of Myriad's detection method claims invalid for lack of ...
 JD Supra1 day ago More Biotech and Diagnostic Patents At Risk After Federal Circuit Decision  Noodls1 day ago Federal Circuit Applies Alice to Biotechnology in Striking Down Myriad Method of Screening Claims, Leaves Door Open for Narrower Method Claims  JD Supra18 hours ago Year in Review 2014: The 10 Most Popular Federal Cir. Blog Posts  Findlaw Corporate Counsel1 day ago

Federal Circuit Upholds e-Commerce Patent as Patent Eligible

In DDR Holdings, LLC v. L.P. (Fed. Cir. Dec. 5, 2014), a split panel of the Federal Circuit held that DDR's e-commerce patent involving an online syndication system governing the interactions of a host website with content from ...
 National Law Review23 hours ago Federal Circuit Finally Meets a Software Patent It Can Love: DDR Holdings, LLC v., et al.  National Law Review1 week ago DDR Holdings v. Federal Circuit Affirms Patent Eligibility for Some Types of Internet-based Claims  National Law Review1 week ago Federal Circuit Finds Patent Claiming Software-Related Invention is Patentable  National Law Review1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less